COMMUNIQUÉS West-GlobeNewswire

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies
07/08/2025
VERO BEACH, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company developing Next Generation Cancer (NGC) therapies for cancer patients, today [...]
SELLAS Life Sciences Announces Independent Data Monitoring Committee Periodic Review and Positive Recommendation to Continue Pivotal Phase 3 REGAL Trial of GPS in AML Without Modification
07/08/2025
- Final Analysis Anticipated by Year-End Upon Occurrence of 80 Events - NEW YORK, Aug. 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical [...]
Intelligent Bio Solutions Announces Preliminary Fiscal Fourth Quarter Revenue with Double-Digit Sequential and Year-Over-Year Growth and Strong Operational Momentum
07/08/2025
Company anticipates fiscal fourth quarter sequential and year-on-year revenue growth of approximately 16% Company advanced efforts to secure U.S. FDA 510(k) clearance for planned U.S. market entry and strengthened [...]
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11
07/08/2025
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company that primarily focuses on [...]
Easy Environmental Solutions introduces Nano Void technology into 2 new industries with orders for systems for local Minnesota businesses
07/08/2025
Expansion into New Industries: Easy Environmental Solutions is installing Nano Void systems at two Minnesota sites—a livestock truck wash and a northern resort—for waste management and lake dredging. Valued at $200,000 [...]
PMV Pharmaceuticals Reports Second Quarter 2025 Financial Results and Corporate Highlights
07/08/2025
PMV will host an investor webinar on Wednesday, September 10, 2025 at 8:00 AM ET to review Phase 2 PYNNACLE clinical trial interim analysis Interim analysis will include data for approximately 65 patients with at least [...]
SS Innovations Reports Second Quarter 2025 Financial Results
07/08/2025
Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth FORT LAUDERDALE, Fla., Aug. 07, 2025 (GLOBE NEWSWIRE [...]
Bill Corl of Omega Laboratories Joins Cannabix Technologies Board of Directors
07/08/2025
VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce William (Bill) R. Corl has [...]
PharmAla Delivers MDMA to Merhavim Mental Health Centre Clinical Trial in Exchange for Full Data License
07/08/2025
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of [...]
Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment
07/08/2025
- ProLectin-M is currently being developed under an active Investigational New Drug (IND) application with the FDA BOSTON, MASSACHUSETTS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), [...]
Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy
07/08/2025
Funds will support advancement of Tevogen.AI, the Company’s artificial intelligence–driven drug discovery initiative. The $1 million is part of up to $10 million in previously announced non-dilutive grant funding from [...]
Alpha Pro Tech, Ltd. Announces Second Quarter 2025 Financial Results
07/08/2025
Second Quarter Net Sales Increased 2.4% to $16.7 Million, Compared to $16.3 Million for the Second Quarter of 2024 Net sales for the second quarter of 2025 were $16.7 million, up 2.4% compared to $16.3 million for the [...]
Accumulus Synergy crée Accumulus Technologies pour développer sa plateforme réglementaire éprouvée et accélérer l’accès mondial aux thérapies
07/08/2025
BURLINGAME, Californie, 07 août 2025 (GLOBE NEWSWIRE) -- Dans une démarche audacieuse visant à accélérer l’innovation réglementaire et à répondre à la demande mondiale croissante, Accumulus Synergy, une association [...]
DeepHealth, a RadNet Subsidiary, Receives FDA Clearance for Remote Scanning Solution, TechLive™
07/08/2025
TechLive™ is a vendor-agnostic integrated solution enabling remote scanning of MR, CT, PET/CT, and Ultrasound procedures Amidst radiology technologist shortages, remote scanning in a command center configuration enables [...]
Enovis Announces Second Quarter 2025 Results
07/08/2025
Continued commercial momentum with second-quarter sales growth of 7% on a reported basis Second-quarter Reconstructive sales grew 11% year-over-year on a reported basis Wilmington, DE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- [...]
LifeStance Reports Second Quarter 2025 Results
07/08/2025
SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation’s largest providers of outpatient mental healthcare, today announced financial results for the second [...]
Dentsply Sirona Reports Second Quarter 2025 Results
07/08/2025
Net sales of $936 million decreased (4.9%) , decreased (6.7%) in constant currency including a (3.2%) Byte sales impact GAAP gross margin of 52.4% , GAAP net loss per share of ($0.22) Adjusted gross margin of 55.9% , [...]
Privia Health Reports Second Quarter 2025 Financial Results
07/08/2025
Very Strong First Half Performance Across All Key Operating and Financial Metrics Implemented Providers +13.8% and Practice Collections +18.5% compared to 2Q’24 Guidance Raised to Above High End of Range for Practice [...]
Sandoz delivers strong H1 2025 results, with accelerated sales growth in the second quarter
07/08/2025
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Basel, August 7, 2025 – Sandoz (SIX: SDZ; OTCQX: SDZNY), the global leader in generic and biosimilar medicines, today presents its [...]

Pages